Amber Beitelshees, PharmD, MPH |
 |
Amber Beitelshees, PharmD, MPH, is Assistant Professor in the Department of Pharmacy Practice at the University of Florida College of Pharmacy. She received her Pharm.D. degree from the University of Florida in 2001. She then completed a residency in Pharmacy Practice at the University of Illinois Medical Center at Chicago. In 2005, Dr. Beitelshees completed her postdoctoral fellowship in Cardiovascular Pharmacogenomics and Master of Public Health degree in epidemiology. After serving on faculty at Washington University in St. Louis School of Medicine she returned to the University of Florida in 2007. Her research is aimed at investigating the metabolic effects of cardiovascular medications and the pharmacogenomics of diabetic cardiovascular disease.
Rhonda Cooper-DeHoff, PharmD, MS |
 |
Dr. Cooper-DeHoff joined the Division of Cardiovascular Medicine Faculty in September 1999, having previously held a research pharmacist position at Shands UF. My primary responsibilities have been focused in research, both clinically and administratively.
In clinical research , she is currently PI on an NIH (NHLBI) funded K23 5 year grant entitled Metabolic Effects of Antihypertensive Drugs. Additionally, Dr. Cooper-DeHoff is a co-investigator on 2 NIH grants focused in the area of pharmacogenetics and hypertension. In 2001 she received a New Investigator Award from the American Heart Association.
In research administration , she serves as the Associate Director for the Clinical Trials Section of the Division of Cardiovascular Medicine. In this capacity she oversees the development, facilitation, and management of investigator initiated and extramurally funded clinical research.
|
Reginald Frye, PharmD, PhD |
 |
Reginald F. Frye, Pharm.D., Ph.D. is Associate Professor in the Department of Pharmacy Practice College of Pharmacy and Associate Director, University of Florida Center for Pharmacogenomics. He received a B.S. in biology from Oglethorpe University, a Pharm.D. from Mercer University School of Pharmacy, and a Ph.D. in Clinical Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy. After completing graduate work, Dr. Frye remained on faculty at the University of Pittsburgh from 1995 until 2003, being promoted to Associate Professor with tenure in 2002. He joined the faculty at the University of Florida in July 2003.
Research Interests
Dr. Frye's clinical research program has focused on the identification and characterization
of factors that contribute to interindividual variability in drug response.
Current focus is on genetic and non genetic (e.g., age, disease) factors that
cause variability in drug metabolism, which can be assessed with in vivo probes
that can measure the activity of specific drug- metabolizing enzymes in individual
subjects. Dr. Frye has received funding for his research from the Pharmaceutical
Industry and the National Institutes of Health.
Search PubMed for Publications
|
Leslie Hendeles,
PharmD |
 |
Research Interests
Leslie Hendeles, PharmD, is Professor of Pharmacy and Pediatrics in the Colleges of Pharmacy and Medicine, at the University of Florida. He received his PharmD degree from the University of Southern California in 1969. His current interests are improving adherence to asthma medications and delivery of inhaled drugs to young children. Dr. Hendeles has authored numerous articles and book chapters on the clinical pharmacology of drugs for asthma and allergic rhinitis. He has received national recognition-for outstanding contribution to the literature from both the American Society of Hospital Pharmacists and the American College of Clinical Pharmacists as well as the American Pharmaceutical Association's award for Lifetime Research Achievement. He is a consultant to the FDA's Pulmonary Division and serves on the Coordinating Committee of NIH's National Asthma Program . The University of Southern California selected him as their 1993 Outstanding Alumnus, and students in the Working Professional Pharm.D. program at UF selected him as their Outstanding Faculty of the Year for 2002. Dr. Hendeles provides advice on drug therapy to physicians and teaches in the Pediatric Pulmonary Clinic at UF.
Search PubMed for Publications
|
Julie
Johnson, Pharm.D.,FCCP,BCPS |
 |
Julie A. Johnson, Pharm.D., FCCP, BCPS is Professor and Chair
of the the Departments of Pharmacy Practice, Professor of Pharmaceutics and
Professor of Medicine (Cardiovascular Medicine) at the University of Florida
Colleges of Pharmacy and Medicine, and Director, University of Florida Center
for Pharmacogenomics. She joined the faculty at the University of Florida in
May 1998. Prior to her appointment on the UF faculty, she spent 9 years on the
University of Tennessee College of Pharmacy faculty. She received her B.S. in
Pharmacy from the Ohio State University and her Pharm.D. from the University
of Texas at Austin and the University of Texas Health Science Center at San
Antonio. Following her Pharm.D., she completed a post-doctoral fellowship in
cardiovascular pharmacology/ pharmacokinetics at the Ohio State University.
Dr. Johnson's research focus is cardiovascular drug pharmacogenomics, disease-gene
associations that may be relevant to pharmacogenomics, and the influence of
race/ethnicity on drug response and pharmacogenomics. She currently has studies
ongoing in the areas of hypertension, heart failure, ischemic heart disease
and obesity, with a primary focus on proteins that are drug targets and the
impact of their genetic polymorphisms on drug response and disease. Her research
has been continuously funded by the National Institutes of Health and/or the
American Heart Association since 1990.
Dr. Johnson is presently serving a four year term on the Nonprescription Drugs
Advisory Committee of the Food and Drug Administration. She is also serving
a five year term on the Pediatric Heart Disease Clinical Research Network Protocol
Review Committee for the National Heart Lung and Blood Institute at NIH. She
is on the editorial boards of the journals Pharmacogenetics and Pharmacotherapy
and serves as manuscript reviewer for numerous other scientific journals.
Dr. Johnson's awards include the University of Tennessee Excellence in Teaching
Award from the Student Government Association (1996), induction as Fellow of
the American College of Clinical Pharmacy (1996), the Ohio State University
Alumni Association William Oxley Thompson Award for early career achievement
(1997), the Outstanding Faculty Award from the University of Florida Working
Professional Pharm.D. Program (2001), the Philip C. and Ethel E. Ashby Lecturer
at the University of Oklahoma (2003), the Albert Ebert 31st Annual Lecturer
at University of Illinois (2003) and the Leon I Goldberg Young Investigator
Award from the American Society for Clinical Pharmacology and Therapeutics (2004).
Taimour Langaee, MSPH, PhD
|
 |
Taimour Y. Langaee, MSPH, Ph.D., is Research Assistant Professor in the Department of Pharmacy Practice at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida.
Dr. Langaee's research interests are focused on pharmacogenetics (genetic-based variability in drug response) in cardiovascular and auto-immune diseases and developing microarray-based technology methods to facilitate disease diagnosis, genotyping of patients and discovering disease-gene associations.
NIH CV
Issam Zineh, PharmD Email:zineh@cop.ufl.edu |
 |
Issam Zineh, Pharm.D., is Assistant Professor in the Department of
Pharmacy Practice at the University of Florida College of Pharmacy. Dr.
Zineh received his Pharm.D. from Northeastern University (Boston) in 2000.
He then went on to Duke University Medical Center where he completed his
residency in Pharmacy Practice. Dr. Zineh came to the University of
Florida as a post-doctoral fellow in cardiovascular pharmacogenomics in
August 2001 and completed his training in December 2003. Currently, his
research focuses on the immunomodulatory effects and pharmacogenetics of
cardiovascular and endocrine drugs commonly used in clinical practice. Dr.
Zineh has received numerous awards for both his research and clinical
service including the American Society for Clinical Pharmacology and
Therapeutics Presidential Trainee Award (2003), the American Heart
Association Florida/Puerto Rico Affiliate Outstanding Postdoctoral Fellow
Award (2002), and the Massachusetts Society of Health-System Pharmacists
Excellence Award (2000). Dr. Zineh has also been trained in or practiced
pharmacy in myriad settings including community pharmacy, managed care,
academic pharmacy, and currently spends a portion of his time as a
pharmacist in the VA Hospital system in North Central Florida. He joined
the College of Pharmacy faculty in January 2004.
Search PubMed
Last modified March 28, 2008